BASF Report 2021 Consoli dated Financial Statements – Notes 217 Segments 2020 Million € Industrial Surface Nutrition & Agricultural Chemicals Materials Solutions Technologies Care Solutions Other BASF Group Sales 8,071 10,736 7,644 16,659 6,019 7,660 2,360 59,149 Intersegment transfers 2,861 720 375 203 429 91 73 4,752 Sales including transfers 10,932 11,456 8,019 16,862 6,448 7,751 2,433 63,901 Income from integral companies accounted for using the equity method 46 16 17 55 4 − 82 220 Income from operations (EBIT) –192 –109 630 –587 688 582 –1,203 –191 Assets 7,896 9,118 6,402 11,691 6,214 14,840 24,131 80,292 of which goodwill 186 179 628 2,019 844 3,039 64 6,959 other intangible assets 53 698 197 1,018 453 3,716 51 6,186 property, plant and equipment 4,362 4,498 2,040 2,973 2,353 2,528 893 19,647 integral investments accounted for using the equity method 710 208 48 414 34 − 464 1,878 Liabilities 3,435 3,893 2,734 2,905 2,948 3,556 26,423 45,894 Research and development expenses 96 182 177 246 160 840 385 2,086 Additions to property, plant and equipment and intangible assets (including acquisitions) 871 1,957 331 585 510 459 156 4,869 Depreciation and amortization of property, plant and equipment and intangible assets 1,429 1,665 469 1,487 464 1,000 171 6,685 of which impairments and reversals of impairmentsa 592 800 106 1,013 53 296 20 2,880 a In 2020, impairments and reversals of impairments only included impairments.